Clinical Update in Pediatric Sepsis: Focus on Children With Pre-Existing Heart Disease

Scott L Weiss1, Susan C Nicolson2, Maryam Y Naim2

  • 1Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Pediatric Sepsis Program, Children's Hospital of Philadelphia, Philadelphia, PA.

Insights

Sepsis is a severe infection causing organ dysfunction in children, particularly those with heart disease. This review covers pediatric sepsis epidemiology, management, and anesthetic considerations.

Area of Science:

  • Pediatric critical care medicine
  • Pediatric cardiology
  • Infectious diseases

Background:

  • Sepsis is a leading cause of childhood morbidity and mortality globally.
  • Children with congenital or acquired heart disease face increased sepsis risk and poorer outcomes.
  • Effective sepsis management involves multidisciplinary collaboration.

Purpose of the Study:

  • To review the epidemiology of pediatric sepsis, focusing on children with heart disease.
  • To compare pediatric and adult sepsis presentations and management.
  • To discuss current hemodynamic guidelines, mechanical circulatory support, and anesthetic management for pediatric sepsis.

Main Methods:

  • Literature review and synthesis of current evidence on pediatric sepsis.
  • Analysis of epidemiological trends and risk factors.
  • Examination of treatment guidelines and supportive care strategies.

Main Results:

  • Pediatric sepsis epidemiology is evolving, with specific challenges in children with heart disease.
  • Hemodynamic management strategies for septic shock in children require adaptation for cardiac patients.
  • Mechanical circulatory support and specialized anesthetic care are crucial in severe cases.

Conclusions:

  • Understanding the nuances of pediatric sepsis, especially in those with heart disease, is critical.
  • Adherence to updated hemodynamic guidelines and consideration of advanced support are essential.
  • Multidisciplinary care optimizes outcomes for children with sepsis and cardiac conditions.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
182
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
329
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
252
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
739
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206